P

Pathalys Pharma

5 employees

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Biopharma

Date founded

2021

Funding rounds raised

Total raised

$150M

from 7 investors over 7 rounds

P

Pathalys Pharma raised $150M on January 18, 2023

Investors: DaVita Venture Group, Catalys Pacific, OrbiMed Advisors, The Carlyle Group and Abingworth

P

Pathalys Pharma raised $11M on June 22, 2021

Investors: DaVita Venture Group and Catalys Pacific

FAQ